arrow
M

Mohammed I. El-Gamal

university of sharjah
H指数:16
被引数:833

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of potential RAF selective back pocket as a promising biological site for BRAF inhibitors targeting resistant melanoma opens the door for a new generation of kinase inhibitors: Design, synthesis, biological evaluation, and in silico molecular simulation

发现潜在的RAF选择性后口袋作为靶向耐药性黑色素瘤的BRAF抑制剂的极具前景的生物位点,为新一代激酶抑制剂打开了大门:设计、合成、生物评价及计算机分子模拟

2025-07-070
OA
Protective potential of Irosustat, STX140 and the sulfonate derivative 1G in counteracting cisplatin-induced renal and hepatic toxicities: An in vivo comparative study

Irosustat、STX140及磺酸酯衍生物1G对抗顺铂诱导的肾毒性及肝毒性的保护潜力:一项体内比较研究

2025-06-050
PRE
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells
2023-12-017
PRE
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors

一系列新的吡唑衍生物的设计,合成和生物学评估: 发现有效和选择性的JNK3激酶抑制剂

2022-09-015
PRE
Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38a kinase inhibitory activity: Synthesis, in vitro assays and in silico study
2022-04-0114
OA
Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity
2021-05-1726
OAAI
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells
2021-01-0118
PREAI